Prosecution Insights
Last updated: October 25, 2026
Application No. 17/492,169

TISSUE REPAIR

Non-Final OA §103§112
Filed
Oct 01, 2021
Priority
Apr 02, 2019 — GB 1904639.0 +2 more
Examiner
IVANOVA, SVETLANA M
Art Unit
1627
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Regenall Limited
OA Round
8 (Non-Final)
51%
Grant Probability
Moderate
8-9
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 51% of resolved cases
51%
Career Allowance Rate
433 granted / 851 resolved
-9.1% vs TC avg
Strong +52% interview lift
Without
With
+51.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
31 currently pending
Career history
886
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
45.2%
+5.2% vs TC avg
§102
14.1%
-25.9% vs TC avg
§112
22.2%
-17.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 851 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 9/11/2026 has been entered. Claim Rejections - 35 USC § 112 Claim Rejections - 35 USC § 103 In view of Applicant’s claim amendments, these rejections are hereby withdrawn. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 35 recites the limitation "A method" in line 1. There is insufficient antecedent basis for this limitation in the claim. The claim depends from claim 36, and therefore the proper term would be “The method”. This is further consistent with the claim language used by Applicant in the other dependent claims. Allowable Subject Matter Claims 1-4, 7, 8, 17-19, 26-32, and 34 are allowable. The application would be in condition for an allowance, if Applicant agrees to cancel withdrawn claims 21-25, and to address the rejection of claim 35 above. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SVETLANA M IVANOVA whose telephone number is (571)270-3277. The examiner can normally be reached 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kortney L. Klinkel can be reached at (571) 270-5239. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SVETLANA M IVANOVA/Primary Examiner, Art Unit 1627
Read full office action

Prosecution Timeline

Show 14 earlier events
Jul 14, 2025
Request for Continued Examination
Jul 15, 2025
Response after Non-Final Action
Aug 12, 2025
Non-Final Rejection mailed — §103, §112
Feb 12, 2026
Response Filed
Mar 12, 2026
Final Rejection mailed — §103, §112
Sep 11, 2026
Request for Continued Examination
Sep 13, 2026
Response after Non-Final Action
Oct 07, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766133
COMPOSITIONS AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
3y 11m to grant Granted Oct 20, 2026
Patent 12758520
GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING
3y 11m to grant Granted Oct 13, 2026
Patent 12740959
METHODS FOR THE TREATMENT OF INFANTILE SPASMS USING MEDIUM CHAIN TRIGLYCERIDES
3y 10m to grant Granted Sep 22, 2026
Patent 12740967
USE OF ATRACTYLENOLIDE I IN PREPARATION OF MEDICINE FOR PREVENTING AND/OR TREATING CERVICAL CANCER
2y 1m to grant Granted Sep 22, 2026
Patent 12733643
FUNGICIDAL COMPOSITIONS
3y 9m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

8-9
Expected OA Rounds
51%
Grant Probability
99%
With Interview (+51.8%)
2y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 851 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month